Abstract
Dysadherin, a small regulator of Na+/K+-ATPase and a cell membrane glycoprotein, is associated with cancer metastasis. However, its role in metastasis is largely unknown. In this review we highlight the role of this recently identified protein in cancer progression. Dysadherin has been suggested to affect cancer progression by downregulating E-cadherin or by upregulating the chemokine production. Overexpression of dysadherin alters trans epithelial resistance (TER) indicating it’s effect on paracellular permeability. Additional findings suggest that dysadherin also affects extracellular matrix. The expression of dysadherin can influence both the tumor cell as well as the cell matrix. Recent findings strongly suggest that dysadherin expression as an independent prognostic indicator of metastasis. Thus, dysadherin can be used as a molecular target for identification as well as prevention of cancer.
| Original language | English |
|---|---|
| Title of host publication | Advances in Biochemistry in Health and Disease |
| Publisher | Springer Nature |
| Pages | 185-193 |
| Number of pages | 9 |
| DOIs | |
| State | Published - 1 Jan 2016 |
| Externally published | Yes |
Publication series
| Name | Advances in Biochemistry in Health and Disease |
|---|---|
| Volume | 15 |
| ISSN (Print) | 2512-2142 |
| ISSN (Electronic) | 2512-2150 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- CCL2
- Cancer
- Dysadherin
- E-cadherin
- FXYD5
- Na/K-ATPase
- RIC
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology (miscellaneous)
- Clinical Biochemistry
- Molecular Medicine
- Physiology
Fingerprint
Dive into the research topics of 'Emerging Role of Dysadherin in Metastasis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver